To amend the Controlled Substances Act to allow for more flexibility with respect to medication-assisted treatment for opioid use disorders and to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.
USA115th CongressHR-5807| House
| Updated: 7/24/2018
Markwayne Mullin
Republican Representative
Oklahoma
Cosponsors (2)
Crime and Federal Government Surveillance Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Substance Use Disorder Coordination, Access, Recovery Enhancement Act of 2018 or the SUD CARE Act This bill increases the maximum number of patients that health care practitioners may initially treat with medication-assisted treatment (i.e., under a buprenorphine waiver), and also aligns federal privacy standards for substance use disorder patient records more closely with standards under the Health Insurance Portability and Accountability Act.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Health
Administrative law and regulatory proceduresCriminal investigation, prosecution, interrogationDepartment of Health and Human ServicesDisability and health-based discriminationDrug, alcohol, tobacco useEmployment discrimination and employee rightsEvidence and witnessesHealth information and medical recordsHealth personnelHealth programs administration and fundingHousing discriminationMedical educationPrescription drugsRight of privacy
To amend the Controlled Substances Act to allow for more flexibility with respect to medication-assisted treatment for opioid use disorders and to amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.
USA115th CongressHR-5807| House
| Updated: 7/24/2018
Substance Use Disorder Coordination, Access, Recovery Enhancement Act of 2018 or the SUD CARE Act This bill increases the maximum number of patients that health care practitioners may initially treat with medication-assisted treatment (i.e., under a buprenorphine waiver), and also aligns federal privacy standards for substance use disorder patient records more closely with standards under the Health Insurance Portability and Accountability Act.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Markwayne Mullin
Republican Representative
Oklahoma
Cosponsors (2)
Crime and Federal Government Surveillance Subcommittee, Judiciary Committee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresCriminal investigation, prosecution, interrogationDepartment of Health and Human ServicesDisability and health-based discriminationDrug, alcohol, tobacco useEmployment discrimination and employee rightsEvidence and witnessesHealth information and medical recordsHealth personnelHealth programs administration and fundingHousing discriminationMedical educationPrescription drugsRight of privacy